Medtronics, Inc.
6
0
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
TAV-in-SAV in Japanese Patients
Role: collaborator
Evaluation of VDD Leadless Pacing System During Exercise
Role: collaborator
Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome
Role: collaborator
UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation
Role: collaborator
Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
Role: collaborator
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
Role: collaborator
All 6 trials loaded